Immunological Insights from Patients Undergoing Surgery on Ipilimumab for Metastatic Melanoma

BACKGROUND. The tumor microenvironment after treatment with ipilimumab is not well described. Furthermore, the safety of surgery for patients being treated with ipilimumab for metastatic melanoma has not been well reported. This study analyzed the safety of surgery and the immune phenotype of tumors...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Ann Surg Oncol
Egile Nagusiak: Gyorki, David E., Yuan, Jianda, Mu, Zhenyu, Zaidi, Bushra, Pulitzer, Melissa, Busam, Klaus, Brady, Mary S., Coit, Daniel G., Allison, James P., Wolchok, Jedd D., Ariyan, Charlotte E.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2013
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6405339/
https://ncbi.nlm.nih.gov/pubmed/23681603
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1245/s10434-013-2999-1
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak